Indication
Hepatic Portal Vein Tumor Invasion
1 clinical trial
1 product
Clinical trial
TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT: A Phase III, Randomized Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2028-08-01
Product
Atezolizumab + Bevacizumab